A Trial to Assess the Safety, Immunogenicity and Efficacy of a Trivalent Rotavirus P2-VP8 Subunit Vaccine in Prevention of Severe Rotavirus Gastroenteritis in Healthy Infants in Africa and India

NCT04010448 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

8200

Enrollment

OTHER

Sponsor class

Conditions

Rotavirus Infection of Children

Interventions

BIOLOGICAL: TV P2-VP8
BIOLOGICAL: Rotarix

Sponsor

PATH

Collaborators

[object Object]
[object Object]